Infertility. Female infertility
Conditions
Interventions
Intervention 1: Control group: Natural cycles with 100 infertile patients will be studied based on the daily serum LH of the 10th cycle day. When the serum LH level will be decreasing, ovulation wil
Treatment - Drugs
Control group: Natural cycles with 100 infertile patients will be studied based on the daily serum LH of the 10th cycle day. When the serum LH level will be decreasing, ovulation will occur 36 to 40
Intervention group:. In hormonal cycles, 4 to 6 mg of Estradiol Valerate tablet will be taken from day 3 of the cycle. This group on 12th cycle day will undergo transvaginal sonography (TVS) for eva
Sponsors
Vice chancellor for research of Iran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
19 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: regular cycle; causes of infertility are male factor; endometriosis; tubal factor; idiopathic; serum levels of FSH is less than or equal to 10 IU/I; normal Prolactin; no allergy to Estradiol and Progesterone; the absence of uterine anomalies Exclusion criteria: patients with oocyte donation will be excluded from this plan
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chemical pregnancy rate. Timepoint: 14 days after embryo transfer. Method of measurement: Beta-HCG using lab kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical pregnancy rate. Timepoint: 7 weeks after embryo transfer. Method of measurement: fetal heart rate in ultra sonography.;Endometrial thickness. Timepoint: From the 12th day of the cycle, one day in between. Method of measurement: Measurement with transvaginal ultrasound. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Ashtari
Iran University of Medical Sciences
Outcome results
None listed